JP2013505950A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505950A5
JP2013505950A5 JP2012531070A JP2012531070A JP2013505950A5 JP 2013505950 A5 JP2013505950 A5 JP 2013505950A5 JP 2012531070 A JP2012531070 A JP 2012531070A JP 2012531070 A JP2012531070 A JP 2012531070A JP 2013505950 A5 JP2013505950 A5 JP 2013505950A5
Authority
JP
Japan
Prior art keywords
milk
derived
composite material
solution
whey
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012531070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505950A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050202 external-priority patent/WO2011038230A2/en
Publication of JP2013505950A publication Critical patent/JP2013505950A/ja
Publication of JP2013505950A5 publication Critical patent/JP2013505950A5/ja
Pending legal-status Critical Current

Links

JP2012531070A 2009-09-24 2010-09-24 代謝疾患の予防および治療のための組成物および方法 Pending JP2013505950A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24550509P 2009-09-24 2009-09-24
US61/245,505 2009-09-24
PCT/US2010/050202 WO2011038230A2 (en) 2009-09-24 2010-09-24 Compositions and methods for the prevention and treatment of metabolic diseases

Publications (2)

Publication Number Publication Date
JP2013505950A JP2013505950A (ja) 2013-02-21
JP2013505950A5 true JP2013505950A5 (enExample) 2013-11-14

Family

ID=43796456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012531070A Pending JP2013505950A (ja) 2009-09-24 2010-09-24 代謝疾患の予防および治療のための組成物および方法

Country Status (8)

Country Link
US (4) US8518453B2 (enExample)
EP (1) EP2480099B1 (enExample)
JP (1) JP2013505950A (enExample)
AU (1) AU2010298141B2 (enExample)
CA (1) CA2775276C (enExample)
NZ (1) NZ599184A (enExample)
RU (1) RU2565020C2 (enExample)
WO (2) WO2011037957A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011037957A2 (en) 2009-09-24 2011-03-31 U.S. Foods & Pharmaceuticals, Inc. Compositions and methods for bone repair, maintenance and regeneration
CN103599521A (zh) * 2013-11-08 2014-02-26 苏州冉新生物技术有限公司 一种复合维生素d冲剂
BE1027357B1 (nl) * 2019-06-12 2021-01-18 Vanlommel Maria Kristel Voedingssupplement voor versnelde genezing

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615664A (en) * 1969-12-05 1971-10-26 Foremost Mckesson Treatment of whey
US3896241A (en) * 1971-09-01 1975-07-22 Coca Cola Co Preparation of a whey protein concentrate
US4572837A (en) * 1984-06-28 1986-02-25 The British Food Manufacturing Industries Research Association Protein product
NL9001692A (nl) * 1990-04-26 1991-11-18 Cooeperatieve Melkproductenbed Werkwijze voor de bereiding van een olie-in-water emulsie.
EP0545946B1 (en) * 1990-07-13 2005-01-19 Gropep Limited Growth-promoting agent
US7033610B2 (en) * 1990-07-13 2006-04-25 Gropep Pty, Ltd. Growth-promoting agent
JP3604159B2 (ja) * 1992-05-07 2004-12-22 雪印乳業株式会社 乳清由来の骨芽細胞増殖促進及び骨強化因子ならびに該因子を含有せしめた骨強化食品、医薬および飼料
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
US5639501A (en) * 1995-01-31 1997-06-17 Vembu; Rajan Separation of minerals from whey permeate
US5912032A (en) * 1995-05-11 1999-06-15 Meiji Milk Products Company, Limited Process of producing calcium-supplemented milk drinks
JP3454487B2 (ja) * 1995-06-29 2003-10-06 雪印乳業株式会社 乳由来カルシウム含有組成物及びその製造方法
JP2974604B2 (ja) * 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
US6139901A (en) * 1997-09-16 2000-10-31 New Zealand Milk Products (North Amerca) Inc. Membrane filtered milk proteins varying in composition and functional attributes
JP4592127B2 (ja) * 1999-03-30 2010-12-01 雪印乳業株式会社 骨吸収抑制剤
JP4701472B2 (ja) * 2000-04-21 2011-06-15 雪印乳業株式会社 乳カルシウム組成物の製造方法
AU784087B2 (en) * 2000-06-09 2006-02-02 Megmilk Snow Brand Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP2001346519A (ja) * 2000-06-09 2001-12-18 Snow Brand Milk Prod Co Ltd 乳塩基性シスタチン高含有画分及びその分解物の製造方法
JP4647750B2 (ja) * 2000-06-20 2011-03-09 雪印乳業株式会社 乳塩基性シスタチン高含有画分及びその分解物の製造法
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
US20030026845A1 (en) * 2001-06-18 2003-02-06 Etzel Lisa R. Process for preparing protein isolate from milk, whey, colostrum, and the like
US20030118662A1 (en) * 2001-12-05 2003-06-26 Glanbia Foods, Inc. Therapeutic uses of milk mineral fortified food products
FR2841747B1 (fr) * 2002-07-02 2004-08-20 Cie Laitiere Europeenne Isolat de proteines de lait et procede pour sa preparation
JP2004115509A (ja) * 2002-09-05 2004-04-15 Snow Brand Milk Prod Co Ltd 破骨細胞分化抑制因子産生促進剤
KR100509177B1 (ko) * 2003-02-05 2005-08-22 롯데제과주식회사 골다공증 예방용 기능성 식품 조성물
JP4536341B2 (ja) * 2003-08-15 2010-09-01 雪印乳業株式会社 骨形成促進剤
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20050208638A1 (en) * 2004-03-22 2005-09-22 Chao Wu Process for preparing bioactive protein-enriched whey products
WO2006058083A2 (en) * 2004-11-24 2006-06-01 Cornell Research Foundation, Inc. Protein and calcium fortification system for clear and opaque beverages
ZA200804292B (en) * 2005-11-30 2009-09-30 Unilever Plc Calcium fortified food product and additive
DE102006009799A1 (de) * 2006-03-01 2007-09-06 Henkel Kgaa Vorwiegend plättchenförmige schwer wasserlösliche Calciumsalze und/oder deren Kompositmaterialien, umfassend diese
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
WO2008028194A2 (en) * 2006-09-01 2008-03-06 Cornell Research Foundation, Inc. Calcium phosphate nanofibers
JP5657200B2 (ja) * 2008-09-05 2015-01-21 サントリー食品インターナショナル株式会社 乳清タンパク質の含有量が低減された乳組成物及び乳入り飲料
WO2011037957A2 (en) 2009-09-24 2011-03-31 U.S. Foods & Pharmaceuticals, Inc. Compositions and methods for bone repair, maintenance and regeneration

Similar Documents

Publication Publication Date Title
CN105361153B (zh) 一种海参糖肽螯合钙的加工方法
FI20115156A0 (fi) Maitopohjainen tuote ja menetelmä sen valmistamiseksi
Sionkowska et al. Fish scales as a biocomposite of collagen and calcium salts
JP2012504947A5 (enExample)
RU2011121825A (ru) Способ получения обессоленного молока и обессоленное молоко
NZ627381A (en) Ruminant feed enhancing energy metabolism in milk production
JP2012012391A5 (enExample)
JP2013505950A5 (enExample)
JP2010505818A5 (enExample)
NZ598888A (en) Method for manufacturing low-phosphorus whey
JP2010162035A5 (enExample)
CN103637255A (zh) 一种即食黑鱼软罐头的制造方法
RU2012114489A (ru) Композиции и способы профилактики и лечения метаболических заболеваний
CN102389047B (zh) 一种用于赛马体力恢复的保健品
BR112014026143A2 (pt) processo para preparação de célula(s)-tronco de leite mamário (bsc) ou um esferoide compreendendo ou consistindo de bsc, célula(s)-tronco de leite mamário (bsc) ou um esferóide compreendendo ou consistindo de bsc, célula(s)-tronco de leite mamário (bsc) isoladas, composição, processo de tratamento da célula em um paciente com necessidade deste, método de tratamento da deficiência de produção de leite em uma lactante fêmea em necessidade deste, e método de tratamento de uma condição de doença em um paciente em necessidade deste
JP2006045233A (ja) 血中脂肪低減用組成物
NZ609198A (en) Her2 dna vaccine as adjunct treatment for cancers in companion animals
CN102907699A (zh) 海参肠的生产方法
Basha et al. Study of metopic suture in south Indian skulls.
JP2016500662A5 (enExample)
KR101451078B1 (ko) 물리ㆍ화학적 처리에 의한 남극크릴새우의 불소 저감화 방법
JP2009060873A (ja) カキ肉を原料とした塩及びその製造方法
CN1857304A (zh) 控缓释型碘的补碘剂及制备方法和用途
CN107648254A (zh) 一种维生素ad及其加工方法
SI1853308T1 (sl) Farmacevtski pripravek za zdravljenje rib ki se ga lahko administrira oralno postopek priprave navedenega pripravka in uporaba le tega